☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
topical
Incyte's Opzelura (ruxolitinib) Receives the US FDA's Approval for the Treatment of Atopic Dermatitis
September 22, 2021
MatriSys Report Results of MSB-0221 in P-I study for the Topical Treatment of Atopic Dermatitis
February 23, 2021
Bausch's Duobrii (Halobetasol Propionate and Tazarotene) Receives FDA's Approval for Topical Treatment of Plaque Psoriasis in Adul...
April 25, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.